The small airways in chronic obstructive pulmonary disease: Pathology and effects on disease progression and survival

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 2, 2013, Pages 109-115

  Stewart, Jeffrey I ^a   Criner, Gerard J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

airflow obstruction; airway inflammation; bronchioles; chronic obstructive pulmonary disease; emphysema; small airways

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; NORFLURANE; PLACEBO;

AEROSOL; AIRWAY REMODELING; APOPTOSIS; BREATH ANALYSIS; CD8+ T LYMPHOCYTE; CELL DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EMPHYSEMA; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG PARENCHYMA; MICRO-COMPUTED TOMOGRAPHY; MORTALITY; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; SMALL AIRWAY DISEASE; SURVIVAL; THICKNESS; TISSUE REPAIR;

DISEASE PROGRESSION; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873448440     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32835ceefc     Document Type: Review

References (29)

1. Kauczor HU, Wielputz MO, Owsijewitsch M, Ley-Zaporozhan J. Computed tomographic imaging of the airways in COPD and asthma. J Thorac Imaging 2011; 26:290-300
2. Vestbo J, Hurd SS, Agusti AG, et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med 2012. doi 10.1164/rccm.201204- 0596PP. [Epub ahead of print
3. Sturton G, Persson C, Barnes PJ. Small airways: An important but neglected target in the treatment of obstructive airway diseases. Trends Pharmacol Sci 2008; 29:340-345
4. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364:709-721
5. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278:1355-1360
6. Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: Direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72:1016-1023
7. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-Airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-2653
8. McDonough JE, Yuan R, Suzuki M, et al. Small-Airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365:1567-1575
9. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291:755-758
10. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1304-1309
11. Burgel P. The role of small airways in obstructive airway diseases. Eur Respir Rev 2011; 20:023-033
12. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360:2445-2454
13. Battaglia S, Mauad T, van Schadewijk AM, et al. Differential distribution of inflammatory cells in large and small airways in smokers. J Clin Pathol 2007; 60:907-911
14. Isajevs S, Taivans I, Svirina D, et al. Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease. Respiration 2011; 81:362-371
15. Sorkness RL, Bleecker ER, Busse WW, et al. Lung function in adults with stable but severe asthma: Air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol 2008; 104:394-403
16. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31:742-750
17. Kim V, Pechulis RM, Abuel-Haija M, et al. Small airway pathology and bronchoreversibility in advanced emphysema. COPD 2010; 7:93-101
18. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978; 298:1277-1281
19. Verbanck S, Schuermans D, Meysman M, et al. Noninvasive assessment of airway alterations in smokers: The small airways revisited. Am J Respir Crit Care Med 2004; 170:414-419
20. Williamson P, Clearie K, Menzies D, et al. Assessment of small-Airways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD. Lung 2011; 189:121-129
21. Mortani Barbosa E Jr, Song G, Tustison N, et al. Computational analysis of thoracic multidetector row HRCT for segmentation and quantification of small airway air trapping and emphysema in obstructive pulmonary disease. Acad Radiol 2011; 18:1258-1269
22. Van Beek EJ, Dahmen AM, Stavngaard T, et al. Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J 2009; 34:1311-1321
23. Hogg JC, Chu FS, Tan WC, et al. Survival after lung volume reduction in chronic obstructive pulmonary disease: Insights from small airway pathology. Am J Respir Crit Care Med 2007; 176:454-459
24. Kim V, Criner GJ, Abdallah HY, et al. Small airway morphometry and improvement in pulmonary function after lung volume reduction surgery. Am J Respir Crit Care Med 2005; 171:40-47
25. Verbanck S, Schuermans D, Paiva M, et al. Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med 2006; 174:853-857
26. Van den Berge M, ten Hacken NH, Cohen J, et al. Small airway disease in asthma and COPD: Clinical implications. Chest 2011; 139:412-423
27. Van Beurden WJ, Harff GA, Dekhuijzen PN, et al. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 2003; 70:242-248
28. John M, Bosse S, Oltmanns U, et al. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease. Respir Med 2005; 99:1418-1424
29. Tatsis G, Kotsifas K, Filaditaki V, et al. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma. J Int Med Res 2007; 35:361-373